Miyaki M, Seki M, Okamoto M, Yamanaka A, Maeda Y, Tanaka K, Kikuchi R, Iwama T, Ikeuchi T, Tonomura A
Department of Biochemistry, Tokyo Metropolitan Institute of Medical Science, Japan.
Cancer Res. 1990 Nov 15;50(22):7166-73.
Loss of heterozygosity (LOH) and K-ras mutation were analyzed in 111 colorectal polyps and 26 invasive carcinomas from 40 patients with familial adenomatous polyposis of distinct histopathological types. LOH, being less than 2% in moderate adenomas, was detected on chromosome 5q (20%) in severe adenomas, on 5q (26%) and 17p (38%) in intramucosal carcinomas, and on 5q (52%), 17p (56%), 18 (46%), and 22q (33%) in invasive carcinomas. LOH on chromosome 5q occurred most frequently in the region close to the APC gene both in adenomas and carcinomas, and a loss of the normal allele of the APC gene was demonstrated in 3 cases. K-ras mutation markedly increased in the step of development from moderate (11%) to severe (36%) adenomas. These results suggest the following mechanisms for the development of colon tumors in patients with familial adenomatous polyposis: (a) the heterozygous mutant/wild-type condition at the APC gene causes formation of mild or moderate adenoma; (b) the loss of the normal allele in the APC gene leads to a change from moderate to severe adenoma; (c) LOH on chromosome 17p contributes to the conversion of adenoma to intramucosal carcinoma; (d) LOH on other chromosomes, such as 18 and 22q, are involved in the progression of intramucosal carcinoma to invasive carcinoma; and (e) K-ras mutation may also affect the development of moderate to severe adenoma.
对40例具有不同组织病理学类型的家族性腺瘤性息肉病患者的111个大肠息肉和26个浸润性癌进行了杂合性缺失(LOH)和K-ras突变分析。中度腺瘤中LOH低于2%,重度腺瘤中5号染色体上检测到LOH(20%),黏膜内癌中5号染色体上为26%、17号染色体短臂上为38%,浸润性癌中5号染色体上为52%、17号染色体短臂上为56%、18号染色体上为46%、22号染色体长臂上为33%。5号染色体上的LOH在腺瘤和癌中最常发生于靠近APC基因的区域,3例中证实存在APC基因正常等位基因的缺失。从中度腺瘤(11%)发展到重度腺瘤(36%)的过程中,K-ras突变显著增加。这些结果提示家族性腺瘤性息肉病患者结肠肿瘤发生的以下机制:(a)APC基因的杂合突变/野生型状态导致轻度或中度腺瘤形成;(b)APC基因正常等位基因的缺失导致从中度腺瘤转变为重度腺瘤;(c)17号染色体短臂上的LOH促使腺瘤转变为黏膜内癌;(d)18号和22号染色体长臂等其他染色体上的LOH参与黏膜内癌进展为浸润性癌;(e)K-ras突变也可能影响中度至重度腺瘤的发生。